Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CAMK2G - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PI3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PHYHIP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PATZ1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ATRAID - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC57399 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors
MMP10 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARL15 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SLX1A-SULT1A3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
GPR17 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MECP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MED27 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CTRB2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC100506504 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR5193 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GH1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACKR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRKRA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WDR45B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PARD3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on